Our finding that MECP2-S423A increases the expression of Bdnf and Nlgn1 in vitro suggests that MECP2 dephosphorylation at S423 in AD brains may be an underlying mechanism mediating neuroprotection. Here, MECP2 is linked to Alzheimer disease.